Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.510
+0.030 (2.03%)
At close: Jan 21, 2025, 4:00 PM
1.600
+0.090 (5.96%)
After-hours: Jan 21, 2025, 4:20 PM EST
Cellectis Market Cap
Cellectis has a market cap or net worth of $156.62 million as of January 21, 2025. Its market cap has decreased by -4.15% in one year.
Market Cap
156.62M
Enterprise Value
92.05M
1-Year Change
-4.15%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $156.62M, a decrease of -88.35%. That is a compound annual growth rate of -19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 148.10M | -17.81% |
| Dec 31, 2024 | 180.20M | 5.26% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |